Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

More possible Alzheimer's treatment

June 14, 1996

XSB-1E as possible Alzheimer's treatment

June 14, 1996

MF-8622 undergoes preclinical evaluation

June 14, 1996

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

GR-92754: Most effective DHFR inhibitor

June 14, 1996

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

TZA-2209: A pure aromatase inhibitor

June 7, 1996

Warner-Lambert reveals indole endothelin antagonists

June 7, 1996

SJC13: LPS-stimulated adhesion inhibitor

June 7, 1996

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...